CD4 and acute lymphoblastic leukemia: In a non-randomized interventional pragmatic clinical trial conducted at our institution, 58 r/r B-ALL patients received 0.89 × 106/kg to 4.01 × 106/kg CAR T cells comprised of CD4+ and CD8+ T cells at a ratio of 1:1 [28].